EstechPharma Co. Ltd (041910) — Cash Flow Reinvestment Rate
EstechPharma Co. Ltd (041910) has a Cash Flow Reinvestment Rate of 2.95x as of December 2025, reinvesting ₩7.02 Billion (capex ₩11.20 Million plus investments ₩7.01 Billion) from operating cash flow of ₩2.38 Billion. See 041910 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
EstechPharma Co. Ltd Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for EstechPharma Co. Ltd across 12 annual periods. For the full cash flow conversion analysis, see EstechPharma Co. Ltd operating cash flow efficiency.
Annual Cash Flow Reinvestment Rate for EstechPharma Co. Ltd (2013–2025)
Year-by-year capital reinvestment analysis for EstechPharma Co. Ltd. See EstechPharma Co. Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.51x | ₩4.53 Billion | ₩8.83 Billion | ₩554.56 Million | ▼ -68.5% |
| 2024 | 1.63x | ₩12.89 Billion | ₩7.93 Billion | ₩5.45 Billion | ▼ -35.7% |
| 2023 | 2.53x | ₩12.10 Billion | ₩4.79 Billion | ₩1.02 Billion | ▼ -83.3% |
| 2021 | 15.11x | ₩9.12 Billion | ₩603.42 Million | ₩2.00 Billion | ▲ +2194.6% |
| 2020 | 0.66x | ₩3.10 Billion | ₩4.71 Billion | ₩2.20 Billion | ▼ -81.5% |
| 2019 | 3.56x | ₩15.27 Billion | ₩4.29 Billion | ₩1.13 Billion | ▲ +2432.7% |
| 2018 | 0.14x | ₩1.02 Billion | ₩7.25 Billion | ₩466.07 Million | ▼ -67.7% |
| 2017 | 0.44x | ₩3.04 Billion | ₩6.99 Billion | ₩691.73 Million | ▲ +37.7% |
| 2016 | 0.32x | ₩2.59 Billion | ₩8.19 Billion | ₩2.09 Billion | ▼ -83.0% |
| 2015 | 1.86x | ₩19.42 Billion | ₩10.46 Billion | ₩4.80 Billion | ▲ +21.9% |
| 2014 | 1.52x | ₩7.60 Billion | ₩4.99 Billion | ₩1.24 Billion | ▲ +959.0% |
| 2013 | 0.14x | ₩1.47 Billion | ₩10.19 Billion | ₩1.47 Billion | — |